Introduction
Acute infectious conjunctivitis is a very common eye disease that is primarily handled in primary care, where it is estimated to constitute approximately 1% of all consultations (Høvding 2008; Azari & Barney 2013) . Every year, one in eight children has symptoms of acute conjunctivitis and the percentage is even higher among younger children (Høvding 2008) . The majority of patients with acute conjunctivitis are treated by general practitioners rather than ophthalmologists (Azari & Barney 2013) .
The difficulty in distinguishing between viral and bacterial conjunctivitis is a common problem (Høvding 2008; Sheikh et al. 2012; Azari & Barney 2013) . In young children, 50-75% of acute conjunctivitis is caused by bacteria (Høvding 2008) , while viral conjunctivitis is more common among adults (Azari & Barney 2013) . Acute bacterial conjunctivitis is most often caused by S. aureus, while cases among young children are also frequently caused by H. influenzae, followed by S. pneumoniae and M. catarrhalis (Høvding 2008; Azari & Barney 2013 ). Viral conjunctivitis is often caused by adenovirus, herpes simplex virus or picornaviruses (Høvding 2008) .
The majority of acute bacterial conjunctivitis cases are self-limiting and treatment is not required in uncomplicated cases (Høvding 2008; Azari & Barney 2013) , as severe complications (keratitis) are rare (Høvding 2008) . While topical ocular antibiotics may lead to a slightly more rapid clinical and microbiological remission of bacterial conjunctivitis, the majority of patients will recover spontaneously without receiving treatment (Sheikh et al. 2012) . Nevertheless, school and day care policies often dictate that children must receive antibiotic treatment before being allowed to return (Finnikin & Jolly 2016) . Consequently, parents exert a substantial pressure on the medical doctor to obtain treatment for their child (Rose et al. 2006) . This is reflected in the fact that topical ocular antibiotics are often prescribed to young children by telephone consultations, that is, without a clinical consultation (Huibers et al. 2014) .
To promote rational use, there is a need for detailed information on prescription patterns of these drugs. Therefore, we aimed to describe the utilization of topical ocular antibiotics in Scandinavian children from 2000 to 2015.
Materials and Methods
We compared individual-level data on topical ocular antibiotics prescribed for 
Data sources
Individual-level data were retrieved from the Danish National Prescription Registry (Potteg ard et al. 2016 ), which covers individual-level information on prescribed medication dispensed from all community pharmacies to Danish residents since 1995. Among other variables, each record includes the substance, the date of purchase and a unique person identifier (Schmidt et al. 2014) . The indication for the prescription is generally not available. Drugs are classified according to WHO's anatomical therapeutic chemical (ATC) system (Guidelines for ATC classification and DDD assignment 2016. Oslo, 2016 n.d.) . The average number of children aged 0-4 years in the study period in Denmark was 346 486 (www.statistikbanken.dk).
Aggregate prescription data were retrieved from the public authorities. Danish data are publicly available at www.medstat.dk , Norwegian data at www.legemiddelforb ruk.no and Swedish data at www.socia lstyrelsen.se/statistik/statistikdatabas/ lakemedel. These data sources hold data on wholesale (amount) drugs used as well as the 'annual period prevalence proportion', that is, the proportion of the population within a given age range that fills at least one prescription for a given drug or drug class in a given calendar year.
In all three countries, all antibiotics, regardless of route of administration, require a prescription from a medical provider.
Population and study drugs
For the individual-level analysis on Danish children, we identified all prescriptions of topical ocular antibiotics issued to a child aged ≤4 years (age at the time of filling the prescription). The age restriction of 0-4 years old was due to the fact that the highest use was observed in this group based on preliminary analyses of publicly available data obtained via Medstat.dk . We included prescriptions for all topical ocular antibiotics, defined as ATC groups S01AA (general antibiotics), S01AB (sulphonamides) and S01AE (fluoroquinolones) at both an individual and aggregate level. For the remainder of the manuscript, the term 'general antibiotics', unless specifically stated, refers to S01AA, that is, topical ocular antibiotics, excluding sulphonamides and fluoroquinolones. The majority of all drugs included within these drug classes were either not marketed in Scandinavian countries during the study period or were very rarely used.
Individual-level analyses (Denmark)
First, to describe the overall rate of treatment, we calculated the annual incidence rate (IR) of treatment episodes with topical ocular antibiotics, defined as the number of treatment episodes per 1000 children (i.e. per 1000 person-years) per year (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) . Clusters of prescriptions separated by <14 days were considered to belong to the same treatment episode. The analysis was stratified by age at the time of filling the prescription (0-1 years and 2-4 years). To illustrate seasonal variation, we further estimated the monthly IR for the last year in the study period (2015) Second, we described the distribution of number of treatment episodes per child by estimating the proportion of all children aged 0-1 years and 2-4 years (defined as age on January 1 in the given year) who received 1, 2 and ≥3 treatment episodes (defined as above) within the given year. Further, for the last year of the study period (2015), we identified children turning 1 through 5 years and identified the number of treatment episodes received in the last 365 days. As an example, for children turning 1 year in 2015, we provided the number of treatment episodes received in the first year of life, and, correspondingly, for children turning 5, the number of treatment episodes received in their fourth year of life.
Lastly, we performed supplementary analyses stratified by region of residency (Region of Southern Denmark, Central Denmark Region, North Denmark Region, Region Zealand, and Capital Region of Denmark) to identify potential regional variation in utilization patterns.
Aggregate data (Scandinavia)
We obtained aggregate data on the annual number of users for topical ocular antibiotics prescribed to children aged 0-4 in Scandinavia for the period from 2000 through 2016. Data from Sweden and Norway were only available from 2004 to 2006, respectively. Using these data, we depicted the annual prevalence (1-year period prevalence) over time in the three countries, that is, the proportion of all children (0-4 years) who received at least one prescription in the given year. Due to the aggregate nature of the data, this analysis had to be performed separately for general antibiotics (ATC, S01AA), sulphonamides (S01AB) and fluoroquinolones (S01AE).
Other
All analyses were performed using STATA 14.2 (StataCorp, College Station, TX, USA). Ethical approval was not required due to the observational nature of the study.
Results

Danish individual-level results
We identified 107 581 Danish children aged 0-4 years who received 271 980 treatment episodes from 2000 through 2015. The average IR of topical ocular antibiotic treatment during the study period was more than twice as high among children aged 0-1 years compared with children aged 2-4 years, with a mean IR per 1000 person-years of 608 compared to 271 (Fig. 1) . The annual IR was relatively stable in both age groups up until 2010, where there was an IR of 728 for children aged 0-1 years and 312 for children aged 2-4 years, after which it decreased by 37% for both age groups until 2015 (when compared to 2010, Fig. 1) . A marked seasonal variation was seen consistently throughout the study period, with the lowest IRs in July-September (data not shown). Only negligible regional variation was seen when stratifying by the five Danish regions (data not shown).
In 2015, 24% of all Danish children aged 0-1 years received one treatment episode, while 6.1% received two treatment episodes and 1.8% received ≥3 treatment episodes. For children aged 2-4, corresponding numbers were 11%, 1.7% and 0.3%, respectively (Fig. 2) . In 2015, the highest proportion of treatment was observed in the second life year, with 42% of the children receiving one or more treatment episodes (Fig. 3) . Most children in this age category received one treatment episode (29.1%), 9.6% had two treatment episodes and 3.3% had ≥3 treatment episodes (Fig. 3) . Similar results were obtained for previous years (data not shown).
Scandinavian results
Compared to Norway and Sweden, Denmark had a markedly higher use of general topical ocular antibiotics (Fig. 4) and fluoroquinolones (Table 1) , with the latter almost exclusively being used in Denmark. The decrease in use observed in Denmark from 2010 and onwards was also observed in Norway and Sweden (Fig. 4) .
The most commonly used single antibiotic substances in the age group 0-4 years in Denmark, Norway and Sweden were chloramphenicol and fusidic acid (selected antibiotics presented in Table 1 ; the full version is available from the corresponding author upon request). The use of tobramycin increased between 2000 and 2010 in Denmark (from 0 to 52 users per 1000 population), followed by a decrease to 24 per 1000 population in 2016 (Table 1 ). In 2016, the prescription of tobramycin in Norway (1 of users per 1000 population) and Sweden (0 users per 1000 population) was limited compared with Denmark (24 users per 1000 population; Table 1 ).
In Denmark, ofloxacin (S01AE01) was the most frequently prescribed fluoroquinolone in 2000-2002 (data not shown), after which ciprofloxacin was more frequently used (Table 1) .
The prescription rate for fluoroquinolones was much lower in Norway (0-2 users per 1000 children) and Sweden (0-1 users per 1000 children; Table 1 ). There were no registrations of sulphonamide prescriptions in Norway and Sweden (data not shown). For Danish data, regarding the sulphonamide group (S01AB), the annual number of prescriptions decreased from 1 to 0 during the study period (data not shown).
Discussion
We found a markedly higher use of topical ocular antibiotics in Denmark compared with Norway and, in particular, Sweden. A decrease was seen in the period 2010-2016 in all three countries. Most antibiotics were prescribed to children aged 0-2 years in Denmark. Further, Danish children received prescriptions for fluoroquinolones and tobramycin, which were rarely used in Norway and Sweden.
There are several strengths to this study. The national prescription registry in each Scandinavian country covers all prescriptions in the age group 0-4 years (Wettermark et al. 2013) . In Scandinavia, all antibiotics require a prescription from a medical provider and can only be purchased at community pharmacies and are thus captured by the data sources used. While antibiotics can also be dispensed directly from hospitals, the proportion of antibiotics supplied in this way is very small and thus unlikely to have influenced our results ). The obtained data include all prescriptions issued by hospitals, general practice and outof-hours primary care, and filled at community pharmacies. Lastly, the use of fill data ensures that prescriptions issued but never filled do not inflate our results (Potteg ard et al. 2014) .
A limitation to our study is the lack of information on indications for prescribing topical ocular antibiotics. Conditions where antibiotics for eye infections are prescribed to children include bacterial conjunctivitis, nasolacrimal duct obstruction with purulent discharge and prophylaxis for ophthalmia neonatorum (Wallace & Steinkuller 1998) . However, in the paediatric population, keratitis is uncommon (Al-Otaibi 2012; Channa et al. 2016) . We thus expect topical ocular antibiotics to be prescribed mainly due to conjunctivitis in our study population.
The overwhelming majority of uncomplicated bacterial conjunctivitis cases are self-limiting (Rose et al. 2005; Rietveld et al. 2007; Høvding 2008; Sheikh et al. 2012; Azari & Barney 2013) , although antibiotics modestly improve the rate of clinical and microbiological remission (Sheikh et al. 2012) . Previous studies in other countries included both children and adults (Rietveld et al. 2007; Shekhawat et al. 2017) . Rietveld et al. (2007) found that more than two-thirds of all episodes of infectious conjunctivitis received topical antibiotic treatment, even though only 21% of cases were registered as bacterial conjunctivitis. Children over the age of 11 years and adults accounted for 75% of the participants (Rietveld et al. 2007) . According to previous studies, viral conjunctivitis is most common among adults (Azari & Barney 2013) , while bacterial conjunctivitis is more common among children (Høvding 2008 ). Therefore, a lower prescription rate would be expected in the Rietveld study.
The significantly higher antibiotic prescription rate observed in Denmark is of concern, as it may indicate an irrational use of topical ocular antibiotics in Denmark. The differences between the three countries may be explained by differences in the healthcare systems. In Norway and Sweden, a contact to the general practitioner usually requires a small fee (although children are exempt), which may lead to a more restrictive behaviour in seeking medical advice for uncomplicated illnesses. Further, national guidelines are available in both Norway and Denmark. In Denmark, the national guideline promotes rational antibiotic use by recommending a wait-and-see policy in moderate bacterial conjunctivitis, while reserving topical antibiotics for more severe cases (Sundhed.dk 2017) . Severe conjunctivitis is defined as excessive lacrimation, redness and oedema both in the conjunctiva and fornices. Only in such cases are children not allowed to return to school or day care before relief of symptoms and treatment with topical antibiotics for at least 2 days (Danish Health Authority 2013). A similar national guideline is present in Norway (The Norwegian Directorate of Health 2016), although specifically promoting the use of delayed prescriptions in mild to moderate cases to relieve symptoms. Both Norwegian and Danish guidelines emphasize that school or day care cannot require parents to seek medical help or initiate topical antibiotics for an eye infection before they reattend. We were not able to identify a national guideline for Sweden. A similar treatment guideline is available in the UK, promoting a 2-week delay before seeing a physician in uncomplicated cases (National Health Service 2018).
School and day care policies often dictate that children have to receive antibiotic treatment before being allowed to return, and, consequently, parents might feel a pressure to obtain treatment for their child (Rose et al. 2006) . In a recent UK study, 87% of childcare policies excluded children with conjunctivitis and 49% required antibiotic treatment, with 43% of healthcare providers reporting to be influenced by childcare polices when prescribing antibiotics and 15% reporting childcare polices to be the sole reason for prescribing (Finnikin & Jolly 2016) . In Denmark, topical ocular antibiotics are often prescribed to children via telephone consultations and during weekends through out-of-hours primary care, that is, without clinical consultations (Huibers et al. 2014) . In general practice, infectious conjunctivitis is often seen as 'catch-up consultations', and physicians find it is easier and less time consuming to prescribe antibiotics than to explain the rationale behind declining to prescribe (Rose et al. 2006) . Another factor that may contribute to prescribing antibiotics is the difficulty in distinguishing between viral and bacterial conjunctivitis (Everitt & Little 2002; Sheikh et al. 2012; Azari & Barney 2013) , with only 36% of general practitioners being certain in their clinical differentiation between the two causes (Everitt & Little 2002) . Furthermore, Everitt and Little (2002) found that 95% of general practitioners prescribed topical ocular antibiotics for acute bacterial conjunctivitis despite the suspicion that half of episodes actually were of viral aetiology. As such, general practitioners often prescribe topical ocular antibiotics due to uncertainty of the aetiology of acute conjunctivitis and lack of knowledge about transmission risk and management (Rose et al. 2006) . Patients who receive treatment for acute infectious conjunctivitis are often convinced that antibiotics promote faster recovery and are more likely to reattend their physician (Everitt et al. 2006 ). Compared to the immediate prescribing of topical antibiotics, delayed General antibiotics  S01AA  314  320  318  291  325  291  289  257  253  226  211  Chloramphenicol  S01AA01  113  106  98  85  98  80  77  69  70  63  60  Tobramycin  S01AA12  27  38  39  38  52  46  45  37  34  26  24  Fusidic acid  S01AA13  224  231  234  215  239  213  212  188  186  166  153  Fluoroquinolones  S01AE  23  25  24  24  28  28  27  24  19  16  11  Ciprofloxacin  S01AE03  16  18  17  18  21  21  20  17  14  12  11  Norway  General antibiotics  S01AA  200  174  204  182  223  190  185  172  170  159  151  Chloramphenicol  S01AA01  126  109  128  111  140  121  117  106  110  105  101  Tobramycin  S01AA12  0  1  1  1  1  1  1  1  0  0  1  Fusidic acid  S01AA13  95  81  97  88  109  88  84  75  71  63  57  Fluoroquinolones  S01AE  2  1  0  0  0  0  0  0  0  0  0  Ciprofloxacin  S01AE03  2  1  0  0  0  0  0  0  0  0  0  Sweden  General antibiotics  S01AA  83  86  82  64  73  60  61  50  53  42  42  Chloramphenicol  S01AA01  41  43  41  31  32  28  19  15  18  16  15  Tobramycin  S01AA12  0  0  0  0  0  0  0  0  0  0  0  Fusidic acid  S01AA13  48  49  47  38  46  36  46  38  38  28  29  Fluoroquinolones  S01AE  1 prescribing reduced the use of antibiotics by 50%, while also reducing reattendance for eye infections and providing similar symptom control compared with immediate prescribing (Everitt et al. 2006) . The decline in rate of topical ocular antibiotics since 2010 deserves mention. A similar decrease has been seen in Denmark for children's use of oral antibiotics (Reilev et al. 2018 ). This points towards increasing adherence to the treatment guidelines outlined above. However, a further reduction of the prescription rate of topical ocular antibiotics seems possible, particularly in Denmark. To this end, it could be considered to introduce delayed prescribing for mild to moderate cases of conjunctivitis into the Danish guidelines, similarly as in the Norwegian guidelines. Besides the differences in overall utilization of topical ocular antibiotics between the three countries, the markedly higher use of tobramycin and fluoroquinolones in Denmark is of concern. While the official Danish guidelines do not dictate choice of antibiotic, a commonly used website among healthcare providers (pro.medicin.dk) lists chloramphenicol, fusidic acid and tobramycin as first line treatment, which might explain the higher rate of tobramycin used in Denmark. We have not identified any guidelines recommending fluoroquinolones, and thus this likely comes down to prescribing tradition.
In conclusion, we have documented considerable variation in the utilization of topical ocular antibiotic prescriptions among children aged 0-4 years in Scandinavia, with Denmark having the highest use, followed by Norway and Sweden. Across the Scandinavian countries, however, a decline was noted from 2010 onwards. A coordinated effort in educating parents, day care institutions and health providers seems necessary to promote the rational use of topical ocular antibiotics for acute infectious conjunctivitis in young children.
